{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:27:54Z","timestamp":1793816874991,"version":"4.6.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG051538"],"award-info":[{"award-number":["AG051538"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG051538"],"award-info":[{"award-number":["AG051538"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG051538"],"award-info":[{"award-number":["AG051538"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG051538"],"award-info":[{"award-number":["AG051538"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG051538"],"award-info":[{"award-number":["AG051538"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG051538"],"award-info":[{"award-number":["AG051538"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG051538"],"award-info":[{"award-number":["AG051538"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Res"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1038\/s41422-019-0241-9","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T01:20:16Z","timestamp":1571966416000},"page":"70-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Initiation of Parkinson\u2019s disease from gut to brain by \u03b4-secretase"],"prefix":"10.1038","volume":"30","author":[{"given":"Eun Hee","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Su","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhentao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu","family":"Chandrasekharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashfaqul M.","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Neish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7657-8154","authenticated-orcid":false,"given":"Keqiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,24]]},"reference":[{"key":"241_CR1","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1172\/JCI29178","volume":"116","author":"JM Savitt","year":"2006","unstructured":"Savitt, J. M., Dawson, V. L. & Dawson, T. M. Diagnosis and treatment of Parkinson disease: molecules to medicine. J. Clin. Invest. 116, 1744\u20131754 (2006).","journal-title":"J. Clin. Invest"},{"key":"241_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.25373","volume":"28","author":"CW Olanow","year":"2013","unstructured":"Olanow, C. W. & Brundin, P. Parkinson\u2019s disease and alpha synuclein: is Parkinson\u2019s disease a prion-like disorder? Mov. Disord. 28, 31\u201340 (2013).","journal-title":"Mov. Disord."},{"key":"241_CR3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.febslet.2004.07.046","volume":"572","author":"Y Hirai","year":"2004","unstructured":"Hirai, Y., Fujita, S. C., Iwatsubo, T. & Hasegawa, M. Phosphorylated alpha-synuclein in normal mouse brain. FEBS Lett. 572, 227\u2013232 (2004).","journal-title":"FEBS Lett."},{"key":"241_CR4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger, R. et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat. Genet 18, 106\u2013108 (1998).","journal-title":"Nat. Genet"},{"key":"241_CR5","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H. et al. Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276, 2045\u20132047 (1997).","journal-title":"Science"},{"key":"241_CR6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz, J. J. et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164\u2013173 (2004).","journal-title":"Ann. Neurol."},{"key":"241_CR7","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Simon-Sanchez","year":"2009","unstructured":"Simon-Sanchez, J. et al. Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat. Genet. 41, 1308\u20131312 (2009).","journal-title":"Nat. Genet."},{"key":"241_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2047-9158-2-16","volume":"2","author":"T Yasuda","year":"2013","unstructured":"Yasuda, T., Nakata, Y., Choong, C. J. & Mochizuki, H. Neurodegenerative changes initiated by presynaptic dysfunction. Transl. Neurodegener. 2, 16 (2013).","journal-title":"Transl. Neurodegener."},{"key":"241_CR9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-8993(99)01848-X","volume":"843","author":"K Arima","year":"1999","unstructured":"Arima, K. et al. Cellular co-localization of phosphorylated tau- and NACP\/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson\u2019s disease and in dementia with Lewy bodies. Brain Res. 843, 53\u201361 (1999).","journal-title":"Brain Res."},{"key":"241_CR10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jnen\/62.4.389","volume":"62","author":"T Ishizawa","year":"2003","unstructured":"Ishizawa, T., Mattila, P., Davies, P., Wang, D. & Dickson, D. W. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. J. Neuropathol. Exp. Neurol. 62, 389\u2013397 (2003).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"241_CR11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1469-1809.2009.00560.x","volume":"74","author":"TL Edwards","year":"2010","unstructured":"Edwards, T. L. et al. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann. Hum. Genet. 74, 97\u2013109 (2010).","journal-title":"Ann. Hum. Genet"},{"key":"241_CR12","doi-asserted-by":"crossref","first-page":"25481","DOI":"10.1074\/jbc.274.36.25481","volume":"274","author":"PH Jensen","year":"1999","unstructured":"Jensen, P. H. et al. alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. J. Biol. Chem. 274, 25481\u201325489 (1999).","journal-title":"J. Biol. Chem."},{"key":"241_CR13","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1082324","volume":"300","author":"BI Giasson","year":"2003","unstructured":"Giasson, B. I. et al. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300, 636\u2013640 (2003).","journal-title":"Science"},{"key":"241_CR14","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1523\/JNEUROSCI.0297-11.2011","volume":"31","author":"EA Waxman","year":"2011","unstructured":"Waxman, E. A. & Giasson, B. I. Induction of intracellular tau aggregation is promoted by alpha-synuclein seeds and provides novel insights into the hyperphosphorylation of tau. J. Neurosci. 31, 7604\u20137618 (2011).","journal-title":"J. Neurosci."},{"key":"241_CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","volume":"154","author":"JL Guo","year":"2013","unstructured":"Guo, J. L. et al. Distinct alpha-synuclein strains differentially promote tau inclusions in neurons. Cell 154, 103\u2013117 (2013).","journal-title":"Cell"},{"key":"241_CR16","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1093\/hmg\/ddu011","volume":"23","author":"B Roy","year":"2014","unstructured":"Roy, B. & Jackson, G. R. Interactions between Tau and alpha-synuclein augment neurotoxicity in a Drosophila model of Parkinson\u2019s disease. Hum. Mol. Genet. 23, 3008\u20133023 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"241_CR17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.tips.2008.03.007","volume":"29","author":"JM Hatcher","year":"2008","unstructured":"Hatcher, J. M., Pennell, K. D. & Miller, G. W. Parkinson\u2019s disease and pesticides: a toxicological perspective. Trends Pharm. Sci. 29, 322\u2013329 (2008).","journal-title":"Trends Pharm. Sci."},{"key":"241_CR18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0005-2728(98)00034-6","volume":"1364","author":"P Lummen","year":"1998","unstructured":"Lummen, P. Complex I inhibitors as insecticides and acaricides. Biochim Biophys. Acta 1364, 287\u2013296 (1998).","journal-title":"Biochim Biophys. Acta"},{"key":"241_CR19","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet, R. et al. Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat. Neurosci. 3, 1301\u20131306 (2000).","journal-title":"Nat. Neurosci."},{"key":"241_CR20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","volume":"34","author":"JR Cannon","year":"2009","unstructured":"Cannon, J. R. et al. A highly reproducible rotenone model of Parkinson\u2019s disease. Neurobiol. Dis. 34, 279\u2013290 (2009).","journal-title":"Neurobiol. Dis."},{"key":"241_CR21","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1046\/j.1471-4159.2000.0752611.x","volume":"75","author":"DJ Talpade","year":"2000","unstructured":"Talpade, D. J., Greene, J. G., Higgins, D. S. Jr. & Greenamyre, J. T. In vivo labeling of mitochondrial complex I (NADH:ubiquinone oxidoreductase) in rat brain using [(3)H]dihydrorotenone. J. Neurochem. 75, 2611\u20132621 (2000).","journal-title":"J. Neurochem."},{"key":"241_CR22","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1523\/JNEUROSCI.22-16-07006.2002","volume":"22","author":"TB Sherer","year":"2002","unstructured":"Sherer, T. B. et al. An in vitro model of Parkinson\u2019s disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J. Neurosci. 22, 7006\u20137015 (2002).","journal-title":"J. Neurosci."},{"key":"241_CR23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.12.003","volume":"22","author":"R Betarbet","year":"2006","unstructured":"Betarbet, R. et al. Intersecting pathways to neurodegeneration in Parkinson\u2019s disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system. Neurobiol. Dis. 22, 404\u2013420 (2006).","journal-title":"Neurobiol. Dis."},{"key":"241_CR24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.nbd.2006.02.012","volume":"23","author":"XF Wang","year":"2006","unstructured":"Wang, X. F., Li, S., Chou, A. P. & Bronstein, J. M. Inhibitory effects of pesticides on proteasome activity: implication in Parkinson\u2019s disease. Neurobiol. Dis. 23, 198\u2013205 (2006).","journal-title":"Neurobiol. Dis."},{"key":"241_CR25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2009.06.017","volume":"36","author":"RE Drolet","year":"2009","unstructured":"Drolet, R. E., Cannon, J. R., Montero, L. & Greenamyre, J. T. Chronic rotenone exposure reproduces Parkinson\u2019s disease gastrointestinal neuropathology. Neurobiol. Dis. 36, 96\u2013102 (2009).","journal-title":"Neurobiol. Dis."},{"key":"241_CR26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2009.04.023","volume":"218","author":"JG Greene","year":"2009","unstructured":"Greene, J. G., Noorian, A. R. & Srinivasan, S. Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson\u2019s disease. Exp. Neurol. 218, 154\u2013161 (2009).","journal-title":"Exp. Neurol."},{"key":"241_CR27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist, S. et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 128, 805\u2013820 (2014).","journal-title":"Acta Neuropathol."},{"key":"241_CR28","doi-asserted-by":"crossref","DOI":"10.1038\/srep00898","volume":"2","author":"F Pan-Montojo","year":"2012","unstructured":"Pan-Montojo, F. et al. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci. Rep. 2, 898 (2012).","journal-title":"Sci. Rep."},{"key":"241_CR29","doi-asserted-by":"crossref","first-page":"38980","DOI":"10.1074\/jbc.M305930200","volume":"278","author":"DN Li","year":"2003","unstructured":"Li, D. N., Matthews, S. P., Antoniou, A. N., Mazzeo, D. & Watts, C. Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo. J. Biol. Chem. 278, 38980\u201338990 (2003).","journal-title":"J. Biol. Chem."},{"key":"241_CR30","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/nm.3700","volume":"20","author":"Z Zhang","year":"2014","unstructured":"Zhang, Z. et al. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer\u2019s disease. Nat. Med. 20, 1254\u20131262 (2014).","journal-title":"Nat. Med."},{"key":"241_CR31","volume":"6","author":"Z Zhang","year":"2015","unstructured":"Zhang, Z. et al. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer\u2019s disease. Nat. Commun. 6, 8762 (2015).","journal-title":"Nat. Commun."},{"key":"241_CR32","volume":"8","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z. et al. Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer\u2019s disease. Nat. Commun. 8, 14740 (2017).","journal-title":"Nat. Commun."},{"key":"241_CR33","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nsmb.3433","volume":"24","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z. et al. Asparagine endopeptidase cleaves alpha-synuclein and mediates pathologic activities in Parkinson\u2019s disease. Nat. Struct. Mol. Biol. 24, 632\u2013642 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"241_CR34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak, H., Ghebremedhin, E., Rub, U., Bratzke, H. & Del Tredici, K. Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res. 318, 121\u2013134 (2004).","journal-title":"Cell Tissue Res."},{"key":"241_CR35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley, L. A. et al. Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57\u201371 (2011).","journal-title":"Neuron"},{"key":"241_CR36","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949\u2013953 (2012).","journal-title":"Science"},{"key":"241_CR37","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.nbd.2011.12.040","volume":"46","author":"K McDowell","year":"2012","unstructured":"McDowell, K. & Chesselet, M. F. Animal models of the non-motor features of Parkinson\u2019s disease. Neurobiol. Dis. 46, 597\u2013606 (2012).","journal-title":"Neurobiol. Dis."},{"key":"241_CR38","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s11064-011-0469-3","volume":"36","author":"H Kaur","year":"2011","unstructured":"Kaur, H., Chauhan, S. & Sandhir, R. Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson\u2019s disease. Neurochem. Res. 36, 1435\u20131443 (2011).","journal-title":"Neurochem. Res."},{"key":"241_CR39","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","volume":"34","author":"RM Santiago","year":"2010","unstructured":"Santiago, R. M. et al. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson\u2019s disease are predominantly associated with serotonin and dopamine. Prog. Neuropsychopharmacol. Biol. Psychiatry 34, 1104\u20131114 (2010).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"241_CR40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"241_CR41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","volume":"396","author":"H Braak","year":"2006","unstructured":"Braak, H., de Vos, R. A., Bohl, J. & Del Tredici, K. Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology. Neurosci. Lett. 396, 67\u201372 (2006).","journal-title":"Neurosci. Lett."},{"key":"241_CR42","doi-asserted-by":"crossref","first-page":"E4016","DOI":"10.1073\/pnas.1309143110","volume":"110","author":"S Janezic","year":"2013","unstructured":"Janezic, S. et al. Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc. Natl. Acad. Sci. USA 110, E4016\u2013E4025 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"241_CR43","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J. Exp. Med. 209, 975\u2013986 (2012).","journal-title":"J. Exp. Med."},{"key":"241_CR44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nlm.2012.12.002","volume":"100","author":"PB Mello-Carpes","year":"2013","unstructured":"Mello-Carpes, P. B. & Izquierdo, I. The Nucleus of the Solitary Tract \u2013> Nucleus Paragigantocellularis \u2013> Locus Coeruleus \u2013> CA1 region of dorsal hippocampus pathway is important for consolidation of object recognition memory. Neurobiol. Learn Mem. 100, 56\u201363 (2013).","journal-title":"Neurobiol. Learn Mem."},{"key":"241_CR45","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1212\/WNL.43.5.986","volume":"43","author":"RM Zweig","year":"1993","unstructured":"Zweig, R. M., Cardillo, J. E., Cohen, M., Giere, S. & Hedreen, J. C. The locus ceruleus and dementia in Parkinson\u2019s disease. Neurology 43, 986\u2013991 (1993).","journal-title":"Neurology"},{"key":"241_CR46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03159935","volume":"14","author":"KA Jellinger","year":"1991","unstructured":"Jellinger, K. A. Pathology of Parkinson\u2019s disease. Changes other than the nigrostriatal pathway. Mol. Chem. Neuropathol. 14, 153\u2013197 (1991).","journal-title":"Mol. Chem. Neuropathol."},{"key":"241_CR47","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1053\/j.gastro.2017.08.069","volume":"153","author":"L Anselmi","year":"2017","unstructured":"Anselmi, L., Toti, L., Bove, C., Hampton, J. & Travagli, R. A. A Nigro-Vagal pathway controls gastric motility and is affected in a rat model of Parkinsonism. Gastroenterology 153, 1581\u20131593 (2017).","journal-title":"Gastroenterology"},{"key":"241_CR48","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","volume":"82","author":"DW Sanders","year":"2014","unstructured":"Sanders, D. W. et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82, 1271\u20131288 (2014).","journal-title":"Neuron"},{"key":"241_CR49","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.neuron.2014.06.004","volume":"82","author":"BT Hyman","year":"2014","unstructured":"Hyman, B. T. Tau propagation, different tau phenotypes, and prion-like properties of tau. Neuron 82, 1189\u20131190 (2014).","journal-title":"Neuron"},{"key":"241_CR50","doi-asserted-by":"crossref","first-page":"aah3374","DOI":"10.1126\/science.aah3374","volume":"353","author":"X Mao","year":"2016","unstructured":"Mao, X. et al. Pathological alpha-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science 353, aah3374 (2016).","journal-title":"Science"},{"key":"241_CR51","doi-asserted-by":"crossref","first-page":"eaat8407","DOI":"10.1126\/science.aat8407","volume":"362","author":"TI Kam","year":"2018","unstructured":"Kam, T. I. et al. Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson\u2019s disease. Science 362, eaat8407 (2018).","journal-title":"Science"},{"key":"241_CR52","doi-asserted-by":"crossref","first-page":"18675","DOI":"10.1074\/jbc.M116.734707","volume":"291","author":"A Tarutani","year":"2016","unstructured":"Tarutani, A. et al. The effect of fragmented pathogenic alpha-synuclein seeds on prion-like propagation. J. Biol. Chem. 291, 18675\u201318688 (2016).","journal-title":"J. Biol. Chem."},{"key":"241_CR53","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1038\/nmicrobiol.2015.21","volume":"1","author":"A Alam","year":"2016","unstructured":"Alam, A. et al. The microenvironment of injured murine gut elicits a local pro-restitutive microbiota. Nat. Microbiol. 1, 15021 (2016).","journal-title":"Nat. Microbiol."},{"key":"241_CR54","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1096\/fj.09-129544","volume":"23","author":"BP Chandrasekharan","year":"2009","unstructured":"Chandrasekharan, B. P. et al. Adenosine 2B receptors (A(2B)AR) on enteric neurons regulate murine distal colonic motility. FASEB J. 23, 2727\u20132734 (2009).","journal-title":"FASEB J."},{"key":"241_CR55","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1523\/JNEUROSCI.6684-10.2011","volume":"31","author":"Z Li","year":"2011","unstructured":"Li, Z. et al. Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development\/survival of enteric dopaminergic neurons. J. Neurosci. 31, 8998\u20139009 (2011).","journal-title":"J. Neurosci."}],"container-title":["Cell Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41422-019-0241-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41422-019-0241-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41422-019-0241-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:18:29Z","timestamp":1684617509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41422-019-0241-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["241"],"URL":"https:\/\/doi.org\/10.1038\/s41422-019-0241-9","relation":{},"ISSN":["1001-0602","1748-7838"],"issn-type":[{"value":"1001-0602","type":"print"},{"value":"1748-7838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,24]]},"assertion":[{"value":"14 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}